View Older Stories View More Recent Stories

Jun 2, 2021 04:03PM Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
May 17, 2021 08:01AM Personalis, Inc. to Present at Biomarkers Week Online 2021
May 5, 2021 04:01PM Personalis Reports First Quarter 2021 Financial Results
Apr 8, 2021 04:07PM Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
Mar 29, 2021 04:03PM Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT Platform™ for Clinical Trials and Companion Diagnostic Development
Mar 8, 2021 05:00PM Personalis Announces Changes to its Board of Directors
Feb 25, 2021 04:01PM Personalis Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 17, 2021 09:01AM Natera and Personalis Partner for Personalized Monitoring in Oncology
Feb 17, 2021 09:00AM Natera and Personalis Partner for Personalized Monitoring in Oncology
Feb 8, 2021 05:13PM Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer
Jan 11, 2021 04:01PM Personalis Reports Preliminary Fourth Quarter 2020 Revenue
Dec 28, 2020 04:01PM Personalis to Present at the 23rd Annual Needham Virtual Growth Conference
Dec 17, 2020 09:09AM Personalis Announces the Launch of NEOPS™, a Neoantigen-based Composite Biomarker for Cancer Immunotherapy Response
Dec 17, 2020 09:07AM Personalis Announces the Launch of SHERPA™ for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
Dec 9, 2020 04:07PM Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
Nov 18, 2020 08:00AM Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event
Nov 16, 2020 09:00AM Personalis® to Present at the AMP Annual Meeting 2020
Nov 9, 2020 04:12PM Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
Nov 5, 2020 04:01PM Personalis Reports Third Quarter 2020 Financial Results
Oct 27, 2020 04:01PM Personalis to Participate in Upcoming Investor Conferences
Oct 22, 2020 04:01PM Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020
Oct 15, 2020 09:02AM Personalis to Participate in Immuno Series US Virtual Meeting
Oct 1, 2020 01:20PM Personalis, Inc. to Present at IO Combinations 360˚
Sep 29, 2020 04:05PM Personalis to Participate in Digital World CB & CDx Meeting
Sep 17, 2020 08:07AM Personalis, Inc. (PSNL) Receives Contract Extension and New Task Order From the VA’s Million Veteran Program
Sep 17, 2020 08:03AM Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175M
Sep 15, 2020 04:01PM Personalis Strengthens Commercial Team with the Appointment of New Head of Population Genomics
Sep 2, 2020 04:01PM Personalis to Participate in Upcoming Investor Conferences
Aug 12, 2020 04:01PM Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 Conference
Aug 6, 2020 04:01PM Personalis Reports Second Quarter 2020 Financial Results
Aug 3, 2020 08:17AM Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform
Jul 23, 2020 04:01PM Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020
Jul 16, 2020 05:15PM Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 16, 2020 08:32AM Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and Development
Jun 24, 2020 08:00AM Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP
Jun 22, 2020 08:00AM Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting
Jun 18, 2020 06:15PM Personalis to Participate in European Association for Cancer Research (EACR) 2020 Virtual Congress
Jun 16, 2020 01:00PM Personalis to Present at the Precision Breast Cancer Summit
Jun 16, 2020 08:00AM Personalis Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 10, 2020 04:05PM Personalis Announces a Partnership with Berry Genomics for China Expansion
Jun 2, 2020 08:00AM Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
May 29, 2020 11:08AM Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting
May 7, 2020 04:01PM Personalis Reports First Quarter 2020 Financial Results
May 5, 2020 02:00PM Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel
Apr 29, 2020 04:05PM Personalis to Participate at Upcoming Investor Conferences
Apr 29, 2020 12:00PM Personalis Announces Renewed Clinical Laboratory Accreditation from College of American Pathologists
Apr 23, 2020 04:05PM Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020
Apr 21, 2020 11:31AM Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Apr 21, 2020 03:00AM Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Apr 14, 2020 11:45AM Personalis, Inc. Expands Genomics Portfolio Across Disease Areas With Launch of Pharma Research Solutions for Use in Early Drug Discovery and Preclinical Studies
View More Recent Stories View Older Stories